Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate

COVID-19 is a respiratory viral disease caused by a new coronavirus called SARS-CoV-2. This disease has spread rapidly worldwide with a high rate of morbidity and mortality. The receptor-binding domain (RBD) of protein spike (S) mediates the attachment of the virus to the host’s cellular receptor. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ávalos, Ileanet, Lao, Thailin, Rodríguez, Elsa María, Zamora, Yasser, Rodríguez, Alianet, Ramón, Ailyn, Lemos, Gilda, Cabrales, Ania, Bequet-Romero, Monica, Casillas, Dionne, Andújar, Ivan, Espinosa, Luis Ariel, González, Luis Javier, Alvarez, Yanitza, Carpio, Yamila, Estrada, Mario Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228316/
https://www.ncbi.nlm.nih.gov/pubmed/35746505
http://dx.doi.org/10.3390/vaccines10060897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228316/
https://www.ncbi.nlm.nih.gov/pubmed/35746505
http://dx.doi.org/10.3390/vaccines10060897

Ejemplares similares